178 related articles for article (PubMed ID: 35861040)
1. CFDP1 promotes hepatocellular carcinoma progression through activating NEDD4/PTEN/PI3K/AKT signaling pathway.
Zhou Y; Qiu J; Liu S; Wang P; Ma D; Zhang G; Cao Y; Hu L; Wang Z; Wu J; Jiang C
Cancer Med; 2023 Jan; 12(1):425-444. PubMed ID: 35861040
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
3. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
4. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
Xiao ZD; Jiao CY; Huang HT; He LJ; Zhao JJ; Lu ZY; Liu LX
Int J Clin Exp Pathol; 2014; 7(7):4039-44. PubMed ID: 25120782
[TBL] [Abstract][Full Text] [Related]
5. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway.
Lv B; Liu X; Zhu X; Huang M
World J Surg Oncol; 2022 Jun; 20(1):175. PubMed ID: 35655254
[TBL] [Abstract][Full Text] [Related]
6. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway.
Wang H; Zhang Q; Cui W; Li W; Zhang J
Cell Cycle; 2021 Oct; 20(20):2125-2136. PubMed ID: 34570663
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
[TBL] [Abstract][Full Text] [Related]
8. NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN.
Zhang R; Ai J; Wang J; Sun C; Lu H; He A; Li M; Liao Y; Lei J; Zhou F; Wu L; Liao W
J Transl Med; 2022 Jul; 20(1):325. PubMed ID: 35864529
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
10. AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway.
Kannan M; Jayamohan S; Moorthy RK; Chabattula SC; Ganeshan M; Arockiam AJV
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698701
[TBL] [Abstract][Full Text] [Related]
11. TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma.
Yin YT; Shi L; Wu C; Zhang MY; Li JX; Zhou YF; Wang SC; Wang HY; Mai SJ
Med Oncol; 2024 Feb; 41(3):79. PubMed ID: 38393440
[TBL] [Abstract][Full Text] [Related]
12. METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN.
Tian QH; Zhang MF; Zeng JS; Luo RG; Wen Y; Chen J; Gan LG; Xiong JP
J Mol Med (Berl); 2019 Nov; 97(11):1535-1545. PubMed ID: 31463732
[TBL] [Abstract][Full Text] [Related]
13. VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway.
Pu Z; Duda DG; Zhu Y; Pei S; Wang X; Huang Y; Yi P; Huang Z; Peng F; Hu X; Fan X
J Transl Med; 2022 May; 20(1):212. PubMed ID: 35562734
[TBL] [Abstract][Full Text] [Related]
14. Rap2B knockdown suppresses malignant progression of hepatocellular carcinoma by inactivating the PTEN/PI3K/Akt and ERK1/2 pathways.
Zhu L; Sun Y; Zhang S; Wang L
Mol Cell Biochem; 2020 Mar; 466(1-2):55-63. PubMed ID: 32052247
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Tu K; Liu Z; Yao B; Han S; Yang W
Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
[TBL] [Abstract][Full Text] [Related]
16. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
[No Abstract] [Full Text] [Related]
17. Oroxin B Induces Apoptosis by Down-Regulating MicroRNA-221 Resulting in the Inactivation of the PTEN/PI3K/AKT Pathway in Liver Cancer.
Li N; Men W; Zheng Y; Wang H; Meng X
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801250
[TBL] [Abstract][Full Text] [Related]
18. Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway.
Chen J; Chen Z; Huang Z; Yu H; Li Y; Huang W
Med Sci Monit; 2019 Jun; 25():4474-4484. PubMed ID: 31203308
[TBL] [Abstract][Full Text] [Related]
19. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
[TBL] [Abstract][Full Text] [Related]
20. DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling.
Zhou H; Du Y; Wei X; Song C; Song J; Xu N; Huang W; Chen L; Yao F; Du D; Qiu C; Zhong L; Liu Y; Gu D; Wang J; Xu Y
Theranostics; 2022; 12(14):6069-6087. PubMed ID: 36168636
[No Abstract] [Full Text] [Related]
[Next] [New Search]